S. Lagström

发表

Novel Activating STAT5B Mutations As Drivers Of T-ALL

S. Mustjoki, O. Kallioniemi, H. Edgren, 2013 .

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

O. Lohi, S. Mustjoki, O. Kallioniemi, 2014, Leukemia.

Gender-Specific Associations Between Saliva Microbiota and Body Size

W. D. de Vos, E. Weiderpass, J. Eriksson, 2019, Front. Microbiol..

High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

S. Bortoluzzi, A. Coppe, S. Mustjoki, 2016, Blood.

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Krister Wennerberg, Tero Aittokallio, Laura Turunen, 2013, Cancer discovery.

the editor: High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia

S. Bortoluzzi, A. Coppe, S. Mustjoki, 2016 .

Differences in integration frequencies and APOBEC3 profiles of five high-risk HPV types adheres to phylogeny

T. Rounge, O. Ambur, S. Lagström, 2022, Tumour virus research.

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

S. Mustjoki, O. Kallioniemi, K. Wennerberg, 2013, Blood.

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

T Aittokallio, W. Huber, T. Aittokallio, 2017, Leukemia.

Abstract 2378: Responses of AML patients to tailored drug regimens: monitoring cancer subclones by ultra-deep resequencing

D. Tamborero, O. Kallioniemi, K. Wennerberg, 2016 .

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis

S. Mustjoki, T. Jaatinen, P. Ellonen, 2017, Nature Communications.

Somatic STAT3 mutations in large granular lymphocytic leukemia.

S. Mustjoki, O. Kallioniemi, K. Wennerberg, 2012, The New England journal of medicine.

Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing

S. Knuutila, M. Rönty, K. Husgafvel‐Pursiainen, 2016, Lung.

Mutated Ephrin Receptor Genes in Non‐Small Cell Lung Carcinoma and Their Occurrence with Driver Mutations—Targeted Resequencing Study on Formalin‐Fixed, Paraffin‐Embedded Tumor Material of 81 Patients

S. Knuutila, M. Rönty, P. Ellonen, 2013, Genes, chromosomes & cancer.

Comparison of Targeted Next‐Generation Sequencing (NGS) and Real‐Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin‐Fixed, Paraffin‐Embedded Tumor Material of Non‐Small Cell Lung Carcinoma—Superiority of NGS

J. Andrews, S. Knuutila, M. Rönty, 2013, Genes, chromosomes & cancer.

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia

S. Bortoluzzi, S. Mustjoki, J. Maciejewski, 2015, Leukemia.

Novel TMEM173 Mutation and the Role of Disease Modifying Alleles

J. Kere, S. Mustjoki, E. Morgunova, 2019, Front. Immunol..

HPV16 and HPV18 type-specific APOBEC3 and integration profiles in different diagnostic categories of cervical samples

M. Nygård, T. Rounge, S. Umu, 2020, medRxiv.

HPV16 whole genome minority variants in persistent infections from young Dutch women.

T. Rounge, O. Ambur, S. Lagström, 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration

P. Ellonen, R. Meisal, T. Rounge, 2019, Scientific Reports.

Intra-host sequence variability in human papillomavirus

Kristina S. Gjøtterud, B. Stray-Pedersen, M. Nygård, 2018, Papillomavirus research.

Reproducibility and repeatability of six high-throughput 16S rDNA sequencing protocols for microbiota profiling.

W. D. de Vos, E. Weiderpass, J. Eriksson, 2018, Journal of microbiological methods.

Reproducibility and repeatability of six high-throughput 16S rDNA sequencing protocols for microbiota profiling

W. D. de Vos, E. Weiderpass, J. Eriksson, 2017, bioRxiv.

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.

S. Mustjoki, G. Mufti, J. Maciejewski, 2013, Blood.

The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia

S. Mustjoki, J. Maciejewski, P. Ellonen, 2015, Haematologica.

A balanced translocation truncates Neurotrimin in a family with intracranial and thoracic aortic aneurysm

J. Terwilliger, A. Palotie, R. Salonen, 2012, Journal of Medical Genetics.

Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping

J. Palefsky, B. Stray-Pedersen, Z. Chirenje, 2021, PloS one.

STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK− ALCL

S. Mustjoki, P. Kovanen, P. Ellonen, 2020, Cancers.

MYELOID NEOPLASIA STAT 3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

S. Mustjoki, G. Mufti, J. Maciejewski, 2013 .

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia

D. Tamborero, O. Kallioniemi, K. Wennerberg, 2016, Leukemia.

Characterization of novel TMEM173 mutation with additive IFIH1 risk allele

J. Kere, S. Mustjoki, E. Morgunova, 2018, bioRxiv.

Simultaneous detection of DNA variation and methylation at HLA class II locus and immune gene promoters using targeted SureSelect Methyl-Sequencing

M. Jagodic, L. Kular, K. Shchetynsky, 2023, Frontiers in immunology.

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

T. Aittokallio, S. Mustjoki, O. Kallioniemi, 2013, Cancer discovery.

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

S. Mustjoki, O. Kallioniemi, K. Wennerberg, 2013, Blood.

Journal of Clinical Virology

T. Rounge, O. Ambur, S. Lagström, 2022 .